Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4073170
Max Phase: Preclinical
Molecular Formula: C27H19Cl2N5O2S2
Molecular Weight: 580.52
Molecule Type: Small molecule
Associated Items:
ID: ALA4073170
Max Phase: Preclinical
Molecular Formula: C27H19Cl2N5O2S2
Molecular Weight: 580.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccccc1NC(=S)NC(=O)c1ccc(CSc2nc(-c3ccc(Cl)cc3Cl)c(C#N)c(=O)[nH]2)cc1
Standard InChI: InChI=1S/C27H19Cl2N5O2S2/c1-15-4-2-3-5-22(15)31-26(37)33-24(35)17-8-6-16(7-9-17)14-38-27-32-23(20(13-30)25(36)34-27)19-11-10-18(28)12-21(19)29/h2-12H,14H2,1H3,(H,32,34,36)(H2,31,33,35,37)
Standard InChI Key: OXVFXKXYHOOBGW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 580.52 | Molecular Weight (Monoisotopic): 579.0357 | AlogP: 6.34 | #Rotatable Bonds: 6 |
Polar Surface Area: 110.67 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 7.00 | CX Basic pKa: | CX LogP: 6.95 | CX LogD: 6.52 |
Aromatic Rings: 4 | Heavy Atoms: 38 | QED Weighted: 0.14 | Np Likeness Score: -2.22 |
1. Cui P, Li X, Zhu M, Wang B, Liu J, Chen H.. (2017) Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors., 27 (10): [PMID:28041832] [10.1016/j.bmcl.2016.11.060] |
Source(1):